RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
 Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Feb 19, 2013 - 1:22:36 AM
News Report
Medical News Channel

subscribe to Medical News newsletter
Medical News

   EMAIL   |   PRINT
Finally, a potential vaccine against kala azar

Nov 27, 2012 - 2:10:04 PM
The IICB findings have been published in the Journal of Molecular Pharmaceutics.

[RxPG] Kolkata, Nov 27 - Scientists at the Indian Institute of Chemical Biology - here claim to have hit the bull's eye with a potential vaccine directed at the dreaded kala azar disease that claims dozens of lives in eastern India every year.

The vaccine formulation is highly potent. We have shown the way and further research will give us a weapon against kala azar, Nahid Ali, scientist at the Infectious Diseases and Immunology Division of the IICB here, told IANS.

Transmitted by the sandfly, it is a slow progressing indigenous disease that leads to infection in the liver and spleen and their enlargement.

Termed by the World Health Organisation as a neglected disease, kala azar, or leishmaniasis as it is known in medical jargon, puts an estimated 165.4 million people at risk in the states of Bihar, Jharkhand, Uttar Pradesh and West Bengal.

Provisional figures by the union health ministry show that kala azar claimed 20 lives and afflicted 14,227 people till July this year.

Despite numerous efforts, there is still no licensed vaccine against kala azar, Ali told IANS.

IICB functions under the Council of Scientific and Industrial Research -.

Now, there is some hope.

To create a vaccine against kala azar, the scientists used what is called the antigen−adjuvant approach.

Generally, an antigen, when introduced into the body, makes it produce antibodies against the substance to deactivate it.

In the case of the kala azar parasite, which resides inside the host cell, the antigen used triggers certain immune cells to fight the parasite.

The adjuvant boosted the body's immune response to the vaccine.

It - is a poor man's disease and drugs are quite expensive. Vaccine formulations will be a big help in the fight against the disease, Pradeep Das, director of the Rajendra Memorial Research Institute of Medical Sciences - in Patna, told IANS.

RMRIMS is mandated by the Indian Council of Medical Research to provide scientific understanding and technology needed to support the fight against kala azar.

The IICB findings have been published in the Journal of Molecular Pharmaceutics.


Related Medical News News
Gogoi announces Rs.5 lakh each to HIV victims, four officials suspended
Woman's complain against hospital dismissed
Apollo Hospital offers senior citizens only OPD
New mental health bill bans electric shocks, gives right to treatment
Caution: Eating Goan frog legs could cause cancer
Assam town protests blood bank's HIV 'mistake'
'Collaboration key to addressing problems of disabled'
Mumbai gets special cancer centre for women
Assam blood bank accused of spreading HIV virus
Re-build society with safe blood transfusion: A.K. Walia

Subscribe to Medical News Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)